FDA-Drug2026-09-02Class IICHEMICAL
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.
Hazard
Subpotent Drug
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0782-2026More Accord Healthcare recalls
- FDA-Drug2026-09-02Accord Healthcare levothyroxine sodium tablets recalled for subpotent drug
- FDA-Drug2026-09-02Accord Healthcare levothyroxine 100 mcg tablets recalled for subpotency
- FDA-Drug2026-09-02Accord Healthcare levothyroxine sodium tablets recalled for subpotent drug
- FDA-Drug2026-09-02Accord Healthcare levothyroxine sodium 150 mcg tablets recalled for subpotent drug
- FDA-Drug2026-09-02Accord Healthcare Levothyroxine Sodium 175 mcg tablets recalled for subpotency
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.